Swallowable Balloon, Semaglutide Improve Obesity-Related OSA

The combined therapy of a swallowable weight-loss balloon and semaglutide oral formulation showed significant reductions in OSA.

Related Keywords

India , Mohit Bhandari , Allurion Program , Allurion Virtual Care Suite , Allurion Connected Scale , Shantanu Gaur ,